ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Dihydrotestosterone

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Hormones, Hormone Substitutes, and Hormone Antagonists ∟ Hormones ∟ Gonadal Hormones ∟ Gonadal Steroid Hormones ∟ Testosterone Congeners ∟ Dihydrotestosterone 13 coordinate concepts 1 subordinate concept ∟ Mesterolone ∟ Androstane-3,17-diol \| ∟ Androstenediol \| ∟ Androstenedione \| ∟ Androsterone \| ∟ Dehydroepiandrosterone \| ∟ Etiocholanolone \| ∟ Nandrolone \| ∟ Testosterone \| ∟ Oxandrolone \| ∟ Oxymetholone \| ∟ Pancuronium \| ∟ Stanozolol \| ∟ Vecuronium Bromide Medical Subject Headings (MeSH) ∟ Polycyclic Compounds ∟ Steroids ∟ Androstanes ∟ Androstanols ∟ Dihydrotestosterone 13 coordinate concepts 1 subordinate concept ∟ Mesterolone ∟ Androstane-3,17-diol \| ∟ Androstenediol \| ∟ Androstenedione \| ∟ Androsterone \| ∟ Dehydroepiandrosterone \| ∟ Etiocholanolone \| ∟ Nandrolone \| ∟ Testosterone \| ∟ Oxandrolone \| ∟ Oxymetholone \| ∟ Pancuronium \| ∟ Stanozolol \| ∟ Vecuronium Bromide X
Broader terms:	Medical Subject Headings (MeSH) ∟ Hormones, Hormone Substitutes, and Hormone Antagonists ∟ Hormones ∟ Gonadal Hormones ∟ Gonadal Steroid Hormones ∟ Testosterone Congeners ∟ Dihydrotestosterone Medical Subject Headings (MeSH) ∟ Polycyclic Compounds ∟ Steroids ∟ Androstanes ∟ Androstanols ∟ Dihydrotestosterone Testosterone Congeners > Gonadal Steroid Hormones > Gonadal Hormones > Hormones > Hormones, Hormone Substitutes, and Hormone Antagonists > Medical Subject Headings (MeSH) Androstanols > Androstanes > Steroids > Polycyclic Compounds > Medical Subject Headings (MeSH) X
Narrower terms:	Mesterolone X
historyNote*:	2004 (1963) X
publicMeSHNote*:	2004; see STANOLONE 1963-2003 X
Scope note:	A potent androgenic metabolite of TESTOSTERONE. Dihydrotestosterone (DHT) is generated by a 5-alpha reduction of testosterone. Unlike testosterone, DHT cannot be aromatized to ESTRADIOL therefore DHT is considered a pure androgenic steroid. X
activeMeSHYear*:	2004 \| 2005 \| 2006 \| 2007X
dateCreated*:	1999-01-01X
dateRevised*:	2003-07-09X
recordAuthorizer*:	sjnX
recordMaintainer*:	lktX
recordOriginator*:	NLMX
Type:	Concept X
Coordinate terms:	Androstane-3,17-diol \| Androstenediol \| Androstenedione \| Androsterone \| Dehydroepiandrosterone \| Etiocholanolone \| Nandrolone \| Testosterone \| Oxandrolone \| Oxymetholone \| Pancuronium \| Stanozolol \| Vecuronium Bromide X
URI:	X
Labels and equivalent concepts:	Dihydrotestosteroni (fi) DHT (fi, replaced) Dihydrotestosteron (sv) Stanolon (sv, replaced) Cuxson Brand of Androstanolone (en, replaced) Stanolone (en, replaced) Besins-Iscovesco Brand of Androstanolone (en, replaced) Berenguer Infale Brand of Androstanolone (en, replaced) 5 alpha-Dihydrotestosterone (en, replaced) 5-alpha-DHT (en, replaced) Androstanolone (en, replaced) 17beta-Hydroxy-5alpha-Androstan-3-One (en, replaced) X
Share:	X